Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02418780 · ClinicalTrials.gov registry record · NA

Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease

A NA study of Parkinson Disease, sponsored by Harvard University Faculty of Medicine.

Completed
Registry status
NA
Development phase
32
Enrollment target
1
Study location

NCT02418780 is a NA study of Parkinson Disease that has completed, run by Harvard University Faculty of Medicine. The registered enrollment target is 32 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02418780, a NA study of Parkinson Disease, has completed, sponsored by Harvard University Faculty of Medicine.

COMPLETED
Registry status
NA
Development phase
32 participants
Enrollment target
1
Study location

Study Summary

The purpose of this feasibility study is to preliminarily evaluate the effects of Tai Chi - a mind-body exercise - on motor and cognitive function as well as quality of life in individuals recently diagnosed with Parkinson's disease (PD).

Conditions Studied

Interventions

  • OTHER Tai Chi

Study Locations (1)

Massachusetts

  • Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 32 participants
Start Date 2014-05
Est. Completion 2016-04
Phase NA

What the Registry Record Tells You About NCT02418780

The ClinicalTrials.gov registry entry for NCT02418780 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The listed sponsor is Harvard University Faculty of Medicine, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 1 intervention - of which Tai Chi is the first listed.

NCT02418780 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02418780 about?

NCT02418780 is a clinical study titled "Tai Chi for Enhancing Motor and Cognitive Function in Parkinson's Disease". The purpose of this feasibility study is to preliminarily evaluate the effects of Tai Chi - a mind-body exercise - on motor and cognitive function as well as quality of life in individuals recently diagnosed with Parkinson's disease (PD).

What is the current status of trial NCT02418780?

This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2014-05. Estimated completion is 2016-04.

What conditions does trial NCT02418780 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT02418780?

The interventions under investigation include: Tai Chi (OTHER).

Who is sponsoring clinical trial NCT02418780?

This trial is sponsored by Harvard University Faculty of Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02418780 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.